Cargando…

Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing

Fibroblastic and myofibroblastic tumors comprise a morphologically diverse and biologically variable group of neoplasms that affect a wide age range. Specific entities tend to occur most frequently in infants and young children. Recent years have witnessed a proliferation of information concerning t...

Descripción completa

Detalles Bibliográficos
Autor principal: Parham, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305242/
https://www.ncbi.nlm.nih.gov/pubmed/30613391
http://dx.doi.org/10.12688/f1000research.16236.1
_version_ 1783382520046288896
author Parham, David M
author_facet Parham, David M
author_sort Parham, David M
collection PubMed
description Fibroblastic and myofibroblastic tumors comprise a morphologically diverse and biologically variable group of neoplasms that affect a wide age range. Specific entities tend to occur most frequently in infants and young children. Recent years have witnessed a proliferation of information concerning the unique biology of these tumors. In this report, I will review recent findings that serve to further characterize this group of neoplasms. Included will be newer information on fibrous hamartoma of infancy, infantile myofibromatosis, lipofibromatosis, and infantile fibrosarcoma and tumors resembling it, including primitive myxoid mesenchymal tumor of infancy and new genetic entities. I will also discuss the differential diagnosis, which includes spindle cell rhabdomyosarcoma, dermatofibrosarcoma protuberans, and calcifying aponeurotic fibroma.
format Online
Article
Text
id pubmed-6305242
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-63052422019-01-03 Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing Parham, David M F1000Res Review Fibroblastic and myofibroblastic tumors comprise a morphologically diverse and biologically variable group of neoplasms that affect a wide age range. Specific entities tend to occur most frequently in infants and young children. Recent years have witnessed a proliferation of information concerning the unique biology of these tumors. In this report, I will review recent findings that serve to further characterize this group of neoplasms. Included will be newer information on fibrous hamartoma of infancy, infantile myofibromatosis, lipofibromatosis, and infantile fibrosarcoma and tumors resembling it, including primitive myxoid mesenchymal tumor of infancy and new genetic entities. I will also discuss the differential diagnosis, which includes spindle cell rhabdomyosarcoma, dermatofibrosarcoma protuberans, and calcifying aponeurotic fibroma. F1000 Research Limited 2018-12-20 /pmc/articles/PMC6305242/ /pubmed/30613391 http://dx.doi.org/10.12688/f1000research.16236.1 Text en Copyright: © 2018 Parham DM http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Parham, David M
Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
title Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
title_full Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
title_fullStr Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
title_full_unstemmed Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
title_short Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
title_sort fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305242/
https://www.ncbi.nlm.nih.gov/pubmed/30613391
http://dx.doi.org/10.12688/f1000research.16236.1
work_keys_str_mv AT parhamdavidm fibroblasticandmyofibroblastictumorsofchildrennewgeneticentitiesandnewancillarytesting